Expert Discussion: PEGASUS-TIMI 54 - Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label data Live from ESC 2017

Expert Discussion: PEGASUS-TIMI 54 - Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label data Live from ESC 2017

Video On Demand

Monday 28th August 2017 @ 14:45 CEST
ESC Congress 2017, Barcelona

Discussants: Dr. Dominic Angiolillo (Jacksonville, US) & Prof. Christoph Varenhorst (Uppsala, SE)

An expert peer-to-peer discussion on the latest data to come out of the PEGASUS-TIMI 54 trial and its implications for clinical practice.

Discussants:

Dr. Dominic Angiolillo (Jacksonville, US)
Dr. Angiolillo joined the University of Florida College of Medicine – Jacksonville in 2004. Currently, Dr. Angiolillo is a professor of medicine with tenure status. He is also the director of Cardiovascular Research, program director of the Interventional Cardiology Fellowship Program and a staff cardiologist and interventional cardiologist with the University of Florida Health System. Dr. Angiolillo is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease and interventional cardiology.

 

Prof. Christoph Varenhorst (Uppsala, SE)
Christoph Varenhorst is associate professor of Cardiology and Senior Consultant Cardiologist at Uppsala University Hospital and Uppsala Clinical Research Center in Uppsala, Sweden. Christoph Varenhorsts research focuses on different aspects of coronary artery disease in both observational real world data sets and experimental clinical trial research.